Table of Contents Table of Contents
Previous Page  66 / 92 Next Page
Information
Show Menu
Previous Page 66 / 92 Next Page
Page Background

64

NCCN Guidelines for Patients

®

Stomach Cancer, Version 1.2016

Guide 11. First-line systemic treatments*

Preferred regimens

Other regimens

Fluoropyrimidine

¥

+ cisplatin

Paclitaxel + cisplatin or carboplatin

Fluoropyrimidine

¥

+ oxaliplatin

Docetaxel + cisplatin

¥

5-FU or capecitabine

Docetaxel

5-FU + irinotecan

Docetaxel + cisplatin + fluorouracil

Docetaxel + oxaliplatin + fluorouracil

Docetaxel + carboplatin + fluorouracil

ECF (epirubicin + cisplatin + fluorouracil)

Epirubicin + oxaliplatin + fluorouracil

Epirubicin + cisplatin + capecitabine

Epirubicin + oxaliplatin + capecitabine

*Trastuzumab should be received with chemotherapy if the cancer cells have too many HER2 receptors.

5

Treatment guide

Metastatic cancer

Guide 12. Second-line systemic treatments

Preferred regimens

Other regimens

Ramucirumab + paclitaxel

Irinotecan + cisplatin

Docetaxel

Irinotecan + fluoropyrimidine (5-FU or capecitabine)

Paclitaxel

Docetaxel + irinotecan

Irinotecan

Docetaxel + irinotecan

Ramucirumab